Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 25;13(23):5918.
doi: 10.3390/cancers13235918.

Reduction in Standard Cancer Screening in 2020 throughout the U.S

Leslie K Dennis  1   2   3 , Chiu-Hsieh Hsu  1   2 , Amanda K Arrington  2   4
Affiliations

Reduction in Standard Cancer Screening in 2020 throughout the U.S

Leslie K Dennis et al. Cancers (Basel). .

Abstract

Cancer screening is an important way to reduce the burden of cancer. The COVID-19 pandemic created delays in screening with the potential to increase cancer disparities in the United States (U.S.). Data from the 2014-2020 Behavioral Risk Factor Surveillance System (BRFSS) survey were analyzed to estimate the percentages of adults who reported cancer screening in the last 12 months consistent with the U.S. Preventive Services Task Force (USPSTF) recommendation for cervical (ages 21-65), breast (ages 50-74), and colorectal cancer (ages 50-75) prior to the pandemic. Cancer screening percentages for 2020 (April-December excluding January-March) were compared to screening percentages for 2014-2019 to begin to look at the impact of the COVID-19 pandemic. Screening percentages for 2020 were decreased from those for 2014-2019 including several underserved racial groups. Decreases in mammography and colonoscopy or sigmoidoscopy were higher among American Indian/Alaskan Natives, Hispanics, and multiracial participants, but decreases in pap test were also highest among Hispanics, Whites, Asians, and African-Americans/Blacks. Decreases in mammograms among women ages 40-49 were also seen. As the 2020 comparison is conservative, the 2021 decreases in cancer screening are expected to be much greater and are likely to increase cancer disparities substantially.

Keywords: COVID-19; cancer screening; colonoscopy; disparities; mammogram; pap test; sigmoidoscopy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Wender R.C., Brawley O.W., Fedewa S.A., Gansler T., Smith R.A. A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control. CA Cancer J. Clin. 2019;69:50–79. doi: 10.3322/caac.21550. - DOI - PubMed
    1. Han H.J., Nwagwu C., Anyim O., Ekweremadu C., Kim S. COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology. Int. Immunopharmacol. 2021;90:107247. doi: 10.1016/j.intimp.2020.107247. - DOI - PMC - PubMed
    1. Wollina U. Challenges of COVID-19 pandemic for dermatology. Dermatol. Ther. 2020;33:e13430. doi: 10.1111/dth.13430. - DOI - PMC - PubMed
    1. Cancino R.S., Su Z., Mesa R., Tomlinson G.E., Wang J. The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities. JMIR Cancer. 2020;6:e21697. doi: 10.2196/21697. - DOI - PMC - PubMed
    1. Crispo A., Montagnese C., Perri F., Grimaldi M., Bimonte S., Augustin L.S., Amore A., Celentano E., Di Napoli M., Cascella M., et al. COVID-19 Emergency and Post-Emergency in Italian Cancer Patients: How Can Patients Be Assisted? Front. Oncol. 2020;10:1571. doi: 10.3389/fonc.2020.01571. - DOI - PMC - PubMed